Table 3.
Between-group comparisons for patient-reported outcomes at 6 and 18 weeks.
| Outcomes | Face-to-face group, mean (SD) | Telerehabilitation group, mean (SD) | Mean difference (95% CI) | |
| Worst knee pain (visual analog scale, range: 0-100) | ||||
|
|
6 weeks | 32.31 (22.51) | 42.31 (23.15) | −10.00 (−26.36 to 6.36) |
|
|
18 weeks | 18.46 (18.46) | 33.08 (22.13) | −14.62 (−31.25 to 2.02) |
| Knee-related quality of life (Knee Injury and Osteoarthritis Outcome Score-Quality of Life subscale, range: 0-100) | ||||
|
|
6 weeks | 63.94 (16.76) | 56.73 (21.87) | 7.21 (−7.27 to 21.69) |
|
|
18 weeks | 68.27 (21.57) | 73.08 (21.71) | −4.81 (−20.56 to 10.95) |
| Disability (Anterior Knee Pain Scale, range: 0-100) | ||||
|
|
6 weeks | 78.54 (12.61) | 77.69 (12.94) | 0.85 (−8.34 to 10.03) |
|
|
18 weeks | 86.54 (10.59) | 84.62 (13.49) | 1.92 (−6.99 to 10.84) |
| Pain catastrophizing (Pain Catastrophizing Scale, range: 0-52) | ||||
|
|
6 weeks | 8.23 (6.92) | 14.46 (10.26) | −6.23 (−13.70 to 0.76) |
|
|
18 weeks | 5.92 (6.02) | 8.54 (9.44) | −2.62 (−8.29 to 3.06) |
| Kinesiophobia (Tampa Scale for Kinesiophobia, range: 17-68) | ||||
|
|
6 weeks | 34.15 (7.72) | 35.31 (5.01) | −1.15 (−6.07 to 3.76) |
|
|
18 weeks | 30.38 (7.12) | 31.77 (5.43) | −1.39 (−6.07 to 3.30) |
| Knee self-efficacy (Knee Self-Efficacy Scale, range: 0-10) | ||||
|
|
6 weeks | 6.95 (0.93) | 6.74 (1.75) | 0.21 (−0.84 to 1.25) |
|
|
18 weeks | 7.64 (1.45) | 7.36 (1.98) | 0.28 (−1.08 to 1.65) |